Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators
Inoue, Kenichi, Ninomiya, Jun, Saito, Tsuyoshi, Kimizuka, Kei, Kurosumi, MasafumiVolume:
18
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-018-4556-6
Date:
December, 2018
File:
PDF, 681 KB
english, 2018